# Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on Periodontium

> **NCT01806974** · PHASE4 · TERMINATED · sponsor: **Nantes University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Periodontitis

## Interventions

- **OTHER:** oral exam and

## Key facts

- **NCT ID:** NCT01806974
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** as the recruitment rate was very low, a futility study was conducted and it was decided to discontinue inclusions
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01806974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01806974, "Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on Periodontium". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01806974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*